2025 Global Trends Report
The State of Customer Engagement in Biopharma
Welcome to the latest Precision AQ Global Trends Report, our free annual publication exploring how customer engagement in biopharma continues to evolve. Drawing on 2025 insights from our Navigator365® research with HCPs, alongside industry perspectives from our Maturometer™ survey, this year’s report looks back at what shaped engagement over the past year – and what it may signal for the year ahead.
'You can't connect the dots looking forward; you can only connect them looking backward.'
- Steve Jobs
:
Get unmissable insights on a range of topics, including:
- HCP engagement preferences – what truly defines a great experience today
- Benchmarking insights – which companies are consistently leading across channels
- Channel performance and the digital divide – where expectations still outpace delivery
- Industry perspectives on omnichannel maturity – confidence, capability and investment trends
- AI in pharma engagement – where HCPs and industry align, and where priorities diverge
- Latest metrics on channel usage and effectiveness – online and offline
To give you a flavour of what’s inside, we’ve highlighted two insights from this year’s report below.
FOR HCPs, THE BEST PHARMA EXPERIENCES ARE USEFUL, EASY AND TIME EFFICIENT
When asked what makes a strong customer experience, HCPs consistently highlight knowledgeable contacts and engagement that is easy to fit into a busy working day. Effective CX isn’t about increasing touchpoints, but rather about delivering expertise through well-timed, well-coordinated interactions. Organisations that focus on relevance, simplicity and timing are best placed to build trust and create engagement that feels genuinely valuable.
Want to find out what matters most to HCPs when it comes to high-quality pharma content?
OPTIMISING THE CUSTOMER EXPERIENCE TOPS THE AGENDA FOR THE NEXT 2 YEARS
Looking ahead, companies plan to prioritise customer journey optimisation and the transformation of field staff into omnichannel reps. Yet ROl measurement and knowledge-building, despite being known bottlenecks, are given lower priority. Of course, progress in CX and ROl only matters relative to competitors – if your scores rise but theirs rise faster, you are still falling behind.
Are companies currently benchmarking in a way that allows them to identify where improvements can be made?
GET STARTED NOW FOR ON-THE-SPOT ACCESS
Discover our in-depth insights on the state of customer engagement in biopharma! Simply complete this short form to download your free 2025 Global Trends Report!
Methodology
Since research began in 2013, our Navigator365 has surveyed more than 65,000 physicians in over 25 therapeutic areas worldwide on their omnichannel preferences and behaviour.
Navigator365 Benchmark allows you to compare your brand to key competitors at the channel and functional (marketing, sales, medical, patient) levels.
Navigator365 Core collates our HCP research into 65 million+ datapoints accessible via the self-service, cloud-based platform through highly interactive tools and reports.
Maturometer surveys colleagues and customers from the life sciences industry, gathering their perspectives on the state of digital transformation in their own organisations in order to assess how well (or not) pharma is progressing along the path to omnichannel maturity.
Looking for more insights to help you shape your customer engagement strategy?
You will find a selection of bite-sized insights, our latest long-read blogs, recorded webinars and other helpful content in our Resources section, all focussed on empowering teams to create stronger engagement and a more seamless customer experience towards their HCP target audiences.